India Mulls 30-Day Extension For Compliance With New Price Caps
This article was originally published in PharmAsia News
Executive Summary
India's drug authorities are considering a 30-day extension of the deadline for drug makers to replace higher-priced drugs on a list of 151 deemed essential with lower-priced batches.